A Study of Hemodialysis Arteriovenous Fistulae Stenosis Treated With APERTO

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 161 participants.

Also called NCT02962141

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 161 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02962141
Other papers using this trial's data
  • Efficacy and Safety of Paclitaxel-Coated Balloon Angioplasty for Dysfunctional Arteriovenous Fistulas: A Multicenter Randomized Controlled Trial American journal of kidney diseases : the official journal of the National Kidney Foundation, 2021-07 DOI, PubMed 33418016

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02962141. Randomized; no masking; primary purpose treatment. Start 2016-10 (registry gives no type); primary completion 2018-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of Hemodialysis Arteriovenous Fistulae Stenosis Treated With APERTO
Condition
Peripheral Arterial Disease
Condition
Fistula
Intervention (Device)
Paclitaxel Releasing Peripheral Balloon Dilatation Catheter
Intervention (Device)
Balloon Dilatation Catheter
Lead sponsor
ZhuHai Cardionovum Medical Device Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct02962141
Content hash
c74ca9d419da8fb2f5deca007c1d79819757e7bf1efa5a1d3a9aaed4deaf8e9c